Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) currently has a “Sell” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Sell” signal. 10 – 8 Day Moving Average Hilo Channel shows “Hold” signal. While 20-Day Moving Average VS Current Price shows “Sell” Signal.
Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) lost -4.15 Percent and closed its previous trading session at $36.45. The stock traded with the average Volume of 1.3 Million at the end of last session.
Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) has the Market Capitalization of 2.42 Billion. The Stock has its 52-week High of $67.10 and 52-Week Low of $30.10 and it touched its 52-week high on 07/19/17 and 52-Week Low on 03/01/18.
The company reported its last earnings Actual EPS of $-1.41/share. While, the analyst predicted that the company could provide an EPS of $-1.46/share. Hence the difference between Predicted EPS and Actual EPS reported is $0.05/share which shows an Earnings Surprise of 3.4 Percent.
Sell side analysts plays vital role in buying and selling a stock where 2 analysts rated Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) as Buy, 0 analysts given Outperform signal, 0 reported Hold, and 0 analysts rated the stock as Sell.
The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -13.54% where SMA50 and SMA200 are -22.1% and -28.59% respectively.
The company shows its Return on Assets (ROA) value of -61.9%. The Return on Equity (ROE) value stands at -109.5%. While it’s Return on Investment (ROI) value is -60.4%.
Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) currently has a Weekly Volatility of 7.46% percent while its Monthly Volatility is at 6.34% percent. While talking about Performance of the Stock, Portola Pharmaceuticals, Inc. currently has a Weekly performance of -2.25%, monthly performance percentage is -17.92 percent, Quarterly performance is -31.25 percent, 6 months performance shows a percent value of -34.57% and Yearly Performance is -5.03 percent.
Portola Pharmaceuticals, Inc. is a biopharmaceutical company .It focuses on the development and commercialization of therapeutics for thrombosis, other hematologic disorders and inflammation. Portola Pharmaceuticals, Inc. is headquartered in South San Francisco, California.